shopping cart
facebook icontwitter iconslinkedin icongoogle icon

GI Effects Mycology Profile - Stool

A Targeted Test for Yeast/Fungi in the Gut

GI Effects is unlike any other stool analysis profile, going beyond the standard parameters for identifying gastrointestinal disorders.

The GI Effects Profile uses DNA analysis to identify microbiota including anaerobes, a previously immeasurable area of the gut environment. DNA assessment is specific and accurate, avoids the pitfalls of sample transport, reports results as specific numbers, and is more sensitive than classic laboratory methods.

Download the White Paper on documented limitations of culture based stool assessment.

The Mycology Profile

The Mycology Profile is also an easy and cost-effective follow-up testing option to monitor targeted therapy in patients for yeast/fungi overgrowth.

Yeast in small amounts is considered normal. However, yeast overgrowth in the gut has been linked to many chronic conditions, in part because of antigenic responses in some patients to even low rates of yeast growth. Potential symptoms can include diarrhea, headache, bloating, atopic dermatitis, and fatigue. The GI Effects Mycology Profile identifies yeast and fungi, in real quantitative amounts, as well as fungal sensitivities of pharmaceuticals and botanicals.

Advantages of the GI Effects Stool Profiles

  • Greater Accuracy
    Microbial DNA analysis improves the accuracy of results and includes both aerobes and anaerobes. Anaerobes comprise over 95% of the bacteria in the gut and are difficult to detect with old culture methods.
  • Antibiotic resistance genes
    DNA analysis detects organisms possessing genes that give rise to antibiotic resistance, offering clinicians a superior tool for effective patient management.
  • Single Sample Collection
    Culture methods require multiple collections, whereas the GI Effects Stool Profile requires only one sample collection leading to improved patient compliance!
  • Eliminates Errors in Transport
    Sample transport is a source of significant error in culture analysis due to the change in microbial balance from the time of collection. Using DNA analysis, the specimen is placed in a fixative tube that stops microbial growth and offers a highly accurate snapshot of the microbial balance in the gut.

Continuing our commitment to innovation

"PCR is the best developed and most widely used nucleic acid amplification strategy...These techniques have sensitivity unparalleled in laboratory medicine, have created new opportunities for the clinical laboratory to have an effect on patient care and have become the new "gold standards" for laboratory diagnosis of several infectious diseases."

-Manual of Clinical Microbiology, 8th Edition, Vol. 1, page 235, 2003